These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 16515689)

  • 1. Influence of liver cancer on lipid and lipoprotein metabolism.
    Jiang J; Nilsson-Ehle P; Xu N
    Lipids Health Dis; 2006 Mar; 5():4. PubMed ID: 16515689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids changes in liver cancer.
    Jiang JT; Xu N; Zhang XY; Wu CP
    J Zhejiang Univ Sci B; 2007 Jun; 8(6):398-409. PubMed ID: 17565510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases.
    Jiang J; Zhang X; Wu C; Qin X; Luo G; Deng H; Lu M; Xu B; Li M; Ji M; Xu N
    Lipids Health Dis; 2008 Jul; 7():25. PubMed ID: 18652652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of abnormal lipoprotein patterns in liver diseases.
    Ooi K; Shiraki K; Sakurai Y; Morishita Y; Nobori T
    Int J Mol Med; 2005 Apr; 15(4):655-60. PubMed ID: 15754028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III.
    Kang SK; Chung TW; Lee JY; Lee YC; Morton RE; Kim CH
    J Biol Chem; 2004 Jul; 279(27):28106-12. PubMed ID: 15123606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.
    Dashti N; Alaupovic P; Knight-Gibson C; Koren E
    Biochemistry; 1987 Jul; 26(15):4837-46. PubMed ID: 2822101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipoprotein metabolism].
    Corvilain B
    Rev Med Brux; 1997 Feb; 18(1):3-9. PubMed ID: 9132915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin.
    Dashti N; Wolfbauer G
    J Lipid Res; 1987 Apr; 28(4):423-36. PubMed ID: 3035039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and significance of lipoprotein(a) in hepatocellular carcinoma.
    Jiang JT; Wu CP; Xu N; Zhang XG
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):25-8. PubMed ID: 19208510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
    Bard JM; Parra HJ; Douste-Blazy P; Fruchart JC
    Metabolism; 1990 Mar; 39(3):269-73. PubMed ID: 2106607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states.
    Heimberg M; Olubadewo JO; Wilcox HG
    Endocr Rev; 1985; 6(4):590-607. PubMed ID: 3908084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of apoprotein synthesis and secretion in the human hepatoma Hep G2. The effect of exogenous lipoprotein.
    Craig WY; Nutik R; Cooper AD
    J Biol Chem; 1988 Sep; 263(27):13880-90. PubMed ID: 2843542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipids, lipoproteins and apolipoproteins levels in patients with nonalcoholic steatohepatitis.
    Koruk M; Savaş MC; Yilmaz O; Tayşi S; Karakok M; Gündoğdu C; Yilmaz A
    J Clin Gastroenterol; 2003 Aug; 37(2):177-82. PubMed ID: 12869892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I.
    Musliner TA; Long MD; Forte TM; Nichols AV; Gong EL; Blanche PJ; Krauss RM
    J Lipid Res; 1991 Jun; 32(6):917-33. PubMed ID: 1940624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
    Groener JE; van Gent T; van Tol A
    Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation.
    Tietge UJ; Boker KH; Bahr MJ; Weinberg S; Pichlmayr R; Schmidt HH; Manns MP
    Hepatogastroenterology; 1998; 45(24):2255-60. PubMed ID: 9951906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of lipoproteins produced by human hepatoma-derived cell lines other than HepG2.
    Forte TM; McCall MR; Knowles BB; Shore VG
    J Lipid Res; 1989 Jun; 30(6):817-29. PubMed ID: 2551986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.